Advancing Affordable Medicines for Families Act This bill requires the Government Accountability Office to report on the potential impact of nonprofit pharmaceutical organizations on the availability and cost of drugs as well as such organizations' potential to accelerate development of new drugs, generic drugs, new biological products, biosimilar products, cell-based therapies, and medical devices.